Diurnal Variation of Sweet Taste Recognition Thresholds Is Absent in Overweight and Obese Humans.

Sanematsu K, Nakamura Y, Nomura M, Shigemura N, Ninomiya Y.
Nutrients. 2018 Mar 2;10(3). pii: E297. doi: 10.3390/nu10030297.

Clodronate: A Vesicular ATP Release Blocker.

Moriyama Y, Nomura M.
Trends Pharmacol Sci. 2018 Jan;39(1):13-23. doi: 10.1016/j.tips.2017.10.007.

Efficacy and safety of metyrosine in pheochromocytoma / paraganglioma: a multi-center trial in Japan.

Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T,
Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K.
Endocr J. 2018 Jan 20. doi: 10.1507/endocrj.EJ17-0276.

Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model.

Kakino S, Ohki T, Nakayama H, Yuan X,
Otabe S, Hashinaga T, Wada N, Kurita Y, Tanaka K, Hara K, Soejima E, Tajiri Y, Yamada K.
Horm Metab Res. 2018 Jan;50(1):80-87. doi: 10.1055/s-0043-118666.

In Vivo Transgene Expression in the Pancreas by the Intraductal Injection of Naked Plasmid DNA.

Yamada Y, Tabata M, Abe J, Nomura M, Harashima H.
J Pharm Sci. 2018 Feb;107(2):647-653. doi: 10.1016/j.xphs.2017.09.021.

Mitochondrial Fission Promotes the Continued Clearance of Apoptotic Cells by Macrophages.

Wang Y, Subramanian M, Yurdagul A Jr, Barbosa-Lorenzi VC, Cai B, de Juan-Sanz J, Ryan TA, Nomura M, Maxfield FR, Tabas I.
Cell. 2017 Oct 5;171(2):331-345.e22. doi: 10.1016/j.cell.2017.08.041.

Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling.

Moriyama Y, Hiasa M, Sakamoto S, Omote H, Nomura M.
Purinergic Signal. 2017 Sep;13(3):387-404. doi: 10.1007/s11302-017-9568-1.

SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes.

Inoue C, Zhao C, Tsuduki Y, Udono M, Wang L, Nomura M, Katakura Y.
NPJ Aging Mech Dis. 2017 Aug 30;3:11. doi: 10.1038/s41514-017-0011-1.

Haemoglobin variants may cause significant differences in haemoglobin A1c as measured by high-performance liquid chromatography and enzymatic methods in diabetic patients: a cross-sectional study.

Otabe S, Nakayama H, Ohki T, Soejima E, Tajiri Y, Yamada K.
Ann Clin Biochem. 2017 Jul;54(4):432-437. doi: 10.1177/0004563216664366.

Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats.

Tokubuchi I, Tajiri Y, Iwata S, Hara K, Wada N, Hashinaga T, Nakayama H, Mifune H, Yamada K.
PLoS One. 2017 Feb 3;12(2):e0171293. doi: 10.1371/journal.pone.0171293.

Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring.

Yamada K, Nakayama H, Yoshinobu S, Kawano S, Tsuruta M, Nohara M, Hasuo R, Akasu S,
Tokubuchi I, Wada N, Hirao S, Iwata S, Kaku H, Tajiri Y.
J Diabetes Investig. 2015 Nov;6(6):699-707. doi: 10.1111/jdi.12370.

Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.

Nakayama H, Kato T, Nakayama S, Kaku H, Muraishi K, Tokubuchi I, Hara K, Kato T, Wada N,
Tsuruta M, Ohki T, Tanaka K, Mitsuzaki K, Tajiri Y, Yamada K.
Intern Med. 2015;54(16):1971-6. doi: 10.2169/internalmedicine.54.4351.

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.

Eguchi H, Tani J, Hirao S, Tsuruta M, Tokubuchi I, Yamada K, Kasaoka M, Teshima Y, Kakuma T, Hiromatsu Y.
Int J Endocrinol. 2015;2015:835979. doi: 10.1155/2015/835979.

Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3).

Ohki T, Utsu Y, Morita S, Karim MF, Sato Y, Yoshizawa T, Yamamura K, Yamada K, Kasayama S, Yamagata K.
J Diabetes Investig. 2014 Sep;5(5):513-6. doi: 10.1111/jdi.12237.

Age-related changes in the diurnal variation of ketogenesis in patients with type 2 diabetes and relevance to hypoglycemic medications.

Nakayama H, Tokubuchi I, Wada N, Tsuruta M, Ohki T, Oshige T, Sasaki Y, Iwata S, Kato N, Ohtsuka Y, Matsuo Y, Tajiri Y, Yamada K.
Endocr J. 2015;62(3):235-41. doi: 10.1507/endocrj.EJ14-0431.

Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes.

Tajiri Y, Kawano S, Hirao S, Oshige T, Iwata S, Ono Y, Inada C, Akashi T, Hayashi H, Sato Y, Tojikubo M, Yamada K.
Int Sch Res Notices. 2014 Aug 3;2014:639489. doi: 10.1155/2014/639489.

Selective modulation of Wnt ligands and their receptors in adipose tissue by chronic hyperadiponectinemia.

Wada N, Hashinaga T, Otabe S, Yuan X, Kurita Y, Kakino S, Ohoki T, Nakayama H, Fukutani T, Tajiri Y, Yamada K.
PLoS One. 2013 Jul 4;8(7):e67712. doi: 10.1371/journal.pone.0067712.

Prevalence and clinical characteristics of unremembered nocturnal eating in diabetic subjects: Kurume sleep trouble in obesity and metabolic disorders (KUSTOMED) study.

Yamada K, Nakayama H, Kato T, Tajiri Y, Sato S, Hirao S, Oshige T, Hara K, Iwata S, Kato N, Sasaki Y, Hasuo R, Yoshinobu S, Mitsuzaki K, Kato T, Hashinaga T, Muraishi K, Ohki T, Kaku H.
Endocr J. 2013;60(9):1059-63.

Modulation by adiponectin of circadian clock rhythmicity in model mice for metabolic syndrome.

Hashinaga T, Wada N, Otabe S, Yuan X, Kurita Y, Kakino S, Tanaka K, Sato T, Kojima M, Ohki T, Nakayama H, Egashira T, Tajiri Y, Yamada K.
Endocr J. 2013;60(4):483-92.

Identification of hepatocyte growth factor activator (Hgfac) gene as a target of HNF1α in mouse β-cells.

Ohki T, Sato Y, Yoshizawa T, Yamamura K, Yamada K, Yamagata K.
Biochem Biophys Res Commun. 2012 Aug 31;425(3):619-24. doi: 10.1016/j.bbrc.2012.07.134.

Long-term efficacy of sitagliptin for the treatment of type 2 diabetic patients in Japan.

Tajiri Y, Tsuruta M, Ohki T, Kato T, Sasaki Y, Tanaka K, Kono S, Tojikubo M, Yamada K.
Endocr J. 2012;59(3):197-204.